Vascepa is a prescription medication that contains the active ingredient icosapent ethyl, which is a type of omega-3 fatty acid. It is used to reduce the risk of cardiovascular events in certain adult patient groups [3].

The FDA-approved label for Vascepa mentions that it may increase the risk of bleeding, especially in patients who are also taking anticoagulant or antiplatelet medications [2]. The label recommends caution when administering Vascepa to patients with a history of bleeding disorders or taking medications that increase the risk of bleeding [2].

The Drug Patent Watch website does not provide information about the potential side effects of Vascepa, but it does list the FDA-approved uses for the medication [1].

In summary, the FDA-approved label for Vascepa warns that it may increase the risk of bleeding, especially in patients who are also taking anticoagulant or antiplatelet medications. Patients with a history of bleeding disorders or taking medications that increase the risk of bleeding should use Vascepa with caution. [2][3]

Sources:
[1] https://www.drugpatentwatch.com/p/tradename/VASCEPA
[2] https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/202057s035lbl.pdf
[3] https://www.fda.gov/news-events/press-announcements/fda-approves-use-drug-reduce-risk-cardiovascular-events-certain-adult-patient-groups